The 2025 Nobel Prize in Physiology or Medicine has been awarded to Mary Brunkow and Fred Ramsdell of the United States, along with Shimon Sakaguchi of Japan, for their groundbreaking discoveries on immune tolerance a process that prevents the body’s own immune system from attacking itself.
The announcement was made by the Karolinska Institute in Stockholm, the body responsible for selecting the Nobel laureates in medicine. Their joint work, which redefined how scientists understand immune regulation, has opened new doors for treating autoimmune diseases and cancer, two of the most challenging medical conditions of our time.
The prize, regarded as the most prestigious recognition in medical science, comes with a monetary award of 11 million Swedish kronor, equivalent to roughly one million Swiss francs.
A Landmark Discovery in Immune Science
For decades, researchers have struggled to understand why the immune system designed to protect us sometimes turns against the body, causing chronic conditions like type 1 diabetes, multiple sclerosis, and rheumatoid arthritis. The work of Brunkow, Ramsdell, and Sakaguchi has shed crucial light on this question.
Their research focused on a special class of immune cells known as regulatory T cells (Tregs). These cells act as a “braking system” for the immune response, ensuring that it attacks harmful invaders such as viruses and bacteria but refrains from damaging healthy tissue.
By identifying and explaining how these Tregs work, the Nobel laureates have provided a molecular understanding of immune tolerance, a discovery that continues to influence medical research and therapeutic innovation worldwide.
How the Discovery Transformed Medicine
Understanding the Body’s Defense System
The human immune system is a complex network of cells and molecules designed to protect the body from infections. However, this same system must also distinguish between foreign invaders and the body’s own cells a delicate balance that, when disrupted, can lead to autoimmune diseases.
The Nobel-winning scientists discovered the exact mechanisms that control this balance. They found that regulatory T cells serve as peacekeepers, preventing other immune cells from mistakenly attacking the body. Without these cells, the immune system can become dangerously overactive.
From Basic Science to Real Treatments
This discovery didn’t just change textbooks it has directly influenced modern medical treatments. Understanding immune tolerance has paved the way for new immunotherapies in cancer, where the goal is to suppress or boost the immune system at the right time.
For example, in autoimmune diseases, therapies are now being developed to enhance Treg activity, calming an immune system that is attacking the body. In contrast, in cancer treatment, researchers are experimenting with temporarily reducing Treg function to allow the immune system to better attack tumor cells.
These insights have given rise to a new era in precision medicine where treatments can be tailored to individual immune profiles, improving both effectiveness and safety.
Statements from the Nobel Committee
Olle Kämpe, chair of the Nobel Committee for Medicine, emphasized the importance of this discovery in a press conference following the announcement.
“We now have a deeper understanding of how the immune system maintains balance and why not everyone develops severe autoimmune conditions,” said Kämpe. “This work has fundamentally reshaped how we think about the immune response.”
The committee highlighted that the laureates’ work represents not only a scientific breakthrough but also a hope for millions of patients suffering from immune-related diseases.
A Legacy of Collaboration and Innovation
Mary Brunkow and Fred Ramsdell: The American Trailblazers
Mary Brunkow and Fred Ramsdell conducted much of their research in the United States, focusing on the genetic and cellular mechanisms behind immune regulation. Their findings helped identify FOXP3, a gene crucial for the development and function of regulatory T cells. Mutations in this gene can lead to severe autoimmune disorders, highlighting the gene’s vital role in immune balance.
Shimon Sakaguchi: The Pioneer from Japan
Meanwhile, Japanese immunologist Shimon Sakaguchi is credited with first discovering regulatory T cells in the 1990s, describing how they suppress excessive immune reactions. His pioneering work laid the foundation for what would become one of the most important fields in immunology.
Together, their combined efforts created a global scientific movement focused on harnessing the immune system’s power safely and effectively.
Future Implications of the Nobel-Winning Research
The implications of their discoveries extend far beyond traditional medicine. Researchers are now exploring how immune tolerance can be manipulated to treat organ transplant rejection, chronic inflammation, and even allergies.
Pharmaceutical companies are investing heavily in Treg-based therapies, and clinical trials are underway across the world. Experts believe that the next decade could see FDA-approved treatments directly inspired by Brunkow, Ramsdell, and Sakaguchi’s work.
As our understanding deepens, the hope is that immune tolerance research will lead to long-term cures rather than temporary symptom management for many chronic conditions.
A Nobel Prize That Redefines the Future of Medicine
The 2025 Nobel Prize in Medicine is more than a recognition of scientific achievement it’s a testament to the power of collaboration and curiosity in unraveling one of biology’s greatest mysteries.
By illuminating how the immune system distinguishes between friend and foe, Brunkow, Ramsdell, and Sakaguchi have changed the landscape of modern medicine. Their work is now guiding researchers, physicians, and biotech innovators toward a future where diseases once deemed incurable may finally be defeated.